Stephens Inc Invitae Corp Transaction History

Stephens Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$24.31 - $33.6 $163,144 - $225,489	-6,711 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $7,383 - $11,433	283 Added 4.4%	6,711 $226,000
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $30,514 - $52,546	923 Added 16.77%	6,428 $246,000
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $156,507 - $245,908	5,505 New	5,505 $239,000
Q2 2020 Aug 24, 2020	SELL	$11.71 - $30.29 $194,678 - $503,571	-16,625 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$7.64 - $27.5 $127,015 - $457,187	16,625 New	16,625 $227,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.